When it comes to strokes, seconds can mean the difference between life, death and lasting damage. That’s why Wellstar Health System is dedicated to developing faster, more effective stroke treatments not just for Georgians, but people across the nation.
Recently, Wellstar Director of Stroke & Neurocritical Care Dr. Rishi Gupta helped test a groundbreaking device to treat complex ischemic strokes, working alongside UCLA’s Dr. Jeffrey Saver and device manufacturer Rapid Medical.
During a two-year period, patients in 16 medical centers across the country were enrolled in a clinical trial to develop the state-of-the-art stroke treatment, with Wellstar registering the highest number of participants.
Dr. Gupta’s efforts will have a profound impact on stroke treatment moving forward, as Wellstar continues to lead the pack when it comes to neuro care.
“Wellstar is on the cutting-edge of many new stroke technologies and therapies, through our participation in groundbreaking clinical trials,” Dr. Gupta explained. “Our research not only brings patients in Georgia the most advanced stroke treatments close to home, but can help save more lives across the country.”
Now, neurointerventionalists nationwide will have access to the new, FDA-approved technology called TIGERTRIEVER™ to help stop strokes faster and improve patient outcomes.
Primary care for you and your family, close to home.